Staxyn is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Vardenafil Hydrochloride.
| Product ID | 0173-0822_1a2c1fa7-6a5f-47e8-a487-1aa4a0e179b5 |
| NDC | 0173-0822 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Staxyn |
| Generic Name | Vardenafil Hydrochloride |
| Dosage Form | Tablet, Orally Disintegrating |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-04-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA200179 |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | VARDENAFIL HYDROCHLORIDE |
| Active Ingredient Strength | 12 mg/1 |
| Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2011-04-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA200179 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-04-21 |
| Marketing Category | NDA |
| Application Number | NDA200179 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-04-21 |
| Marketing End Date | 2020-02-28 |
| Marketing Category | NDA |
| Application Number | NDA200179 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-04-21 |
| Marketing End Date | 2019-01-24 |
| Ingredient | Strength |
|---|---|
| VARDENAFIL HYDROCHLORIDE | 11.85 mg/1 |
| SPL SET ID: | 0e5139d8-bf61-4f21-a36b-81b96b9b07d1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0173-0822 | Staxyn | vardenafil hydrochloride |
| 0173-0829 | Levitra | vardenafil hydrochloride |
| 0173-0830 | Levitra | vardenafil hydrochloride |
| 0173-0831 | Levitra | vardenafil hydrochloride |
| 0093-7652 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0093-7653 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0093-7654 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0093-7655 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0527-2800 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0527-2801 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0527-2802 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
| 0527-2803 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() STAXYN 77600029 4035352 Live/Registered |
BAYER AKTIENGESELLSCHAFT 2008-10-24 |